期刊文献+

CHD5基因RNAi慢病毒载体的构建及其对结直肠癌细胞生物学功能的影响 被引量:2

Construction of Recombinant Lentiviral Vector of shRNA for CHD5 Gene and the Study of Its Functions in Human Colon Carcinoma Lovo Cells
原文传递
导出
摘要 目的:研究人类肿瘤相关基因CHD5基因miR-shRNA慢病毒对结直肠癌Lovo细胞的影响。方法:利用软件设计对CHD5基因干扰有效的序列,合成靶序列,退火形成双链DNA,酶切后与载体相连接。将重组慢病毒载体pPRIME-TET-GFP-CHD5与慢病毒包装质粒pCMV-VSV-G,pRSV-Rev,pMDLg-pRRE共转染293FT细胞,将包装重组慢病毒感染人类结直肠癌Lovo细胞。通过荧光定量PCR和Western blot验证CHD5基因在细胞中的表达情况,应用MTT检测CHD5低表达对Lovo细胞增殖的影响。结果:成功构建pPRIME-TET-GFP-CHD5重组质粒,经酶切及序列测定正确,包装的病毒滴度为3.1×106TU/ml。用制备的病毒上清感染Lovo细胞后,荧光定量PCR和Western blot分析结果显示该慢病毒可分别在转录和蛋白质水平上抑制Lovo细胞CHD5基因的表达,并使得Lovo细胞增殖失控。结论:成功构建CHD5慢病毒表达载体,表达的慢病毒可有效的感染Lovo细胞,提高Lovo细胞的增殖能力。 To study the effects of lentiviral vector of microRNA targeting CHD5 gene on human colon carcinoma Lovo cell.Methods: Specific small interference RNAs were designed on line software and screened with the optimize principles,synthesized and cloned into the pPRIME vetor.Recombinant lentiviral was producted by 293FT cells following co-transfection of pPRIME-TET-GFP-CHD5 with the packaging plasmids pCMV-VSV-G,pRSV-Rev and pMDLg-pRRE.Human colon carcinoma Lovo cell were infected by the recombinant lentivirus.The expression of CHD5 was confirmed by RT-PCR and Western blotting,and the proliferation of Lovo cells was evaluated by MTT assay.Results: The recombinant lentiviral vecor carried the CHD5 gene was successfully constructed by restriction enzyme digestion and sequencing,respectively.The packaged lentiviral titer was 3.1×106 TU/ml.RT-PCR and Western blot analysis revealed that pPRIME-TET-GFP-CHD5 infection inhibited CHD5 mRNA and protein expressions in Lovo cells.The proliferation of Lovo cells was increased.Conclusion: The recombinant lentiviral vector pPRIME-TET-GFP-CHD5 was constructed successfully.It can be deliver target gene to human colon carcinoma Lovo cell,and inhibit CHD5 can promoted the proliferation of colon carcinoma Lovo cell.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2012年第5期7-11,共5页 China Biotechnology
基金 国家青年科学基金(81000226) 广东省自然科学基金(S2011040005521)资助项目
关键词 CHD5 基因 miR-shRNA RNAI 技术 CHD5 gene miR-shRNA RNAi
  • 相关文献

参考文献17

  • 1Brodeur G M, Maris J M, Yamashiro D J, et al. Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol, 1997,19 (2) :93-101.
  • 2Hogarty M D, Liu X, Guo C, et al. Identification of a 1- megabase consensus region of deletion at lp36. 3 in primary neuroblastomas. Med Pediatr Oncol, 2000, 35 ( 6 ) : 512 -515.
  • 3Maris J M, Guo C, Blake D, et al. Comprehensive analysis of chromosome 1 p deletions in neuroblastoma. Med Pediatr Oncol, 2001, 36( 1 ) :32-36.
  • 4White P S, Maris J M, Sulman E P, et al. Molecular analysis ofthe region of distal 1 p commonly deleted in neuroblastoma. Eur J Cancer, 1997,33(2) :1957-1961.
  • 5Bagchi A, Papazoglu C, Wu Y, et al. CHD5 is a tumor suppressor at human 1 p36. Cell, 2007,128 (3) : 459-475.
  • 6Camirand A, Lu Y, Pollak M. Co-targeting HER2/ErbB2 and insulin-like growth factor-1 receptors causes synergistic inhibition of growth in HER2-overexpressing breast cancer ceils. Med Sci Monit, 2002, 8 (12) :521-526.
  • 7Morris K V, Rossi J J. Lentiviral mediated delivery of siRNAs for antiviral therapy. Gene Ther, 2006, 13 (6) :553-558.
  • 8Kock N, Kasmieh R, Weissleder R, et al. Tumor Therapy Mediated by Lentiviral Expression of shBcl-2 and S-TRAIL. Neoplasia, 2007, 9 (5) :435-442.
  • 9Cockrell A S, Kafri T. Gene delivery by lentivirus vectors. Mol Biotechnol, 2007, 36 (3):184-204.
  • 10Sumimoto H, Kawakami Y. Lentiviral vector mediated RNAi and its use for cancer research. Future Oncol, 2007, 3 ( 6 ) : 655-664.

同被引文献19

  • 1Sharrard RM,Royds JA,Rogers S,et al. Patterns of methy-lation of the c-myc gene in human colorectal cancer progres-sion [J ].Br J Cancer, 1992,65 : 667 -672.
  • 2White PS, Thompson PM, Gotoh T, et al. Definition andcharacterization of a region of lp36. 3 consistently deleted inneuroblastoma [ J ] . Oncogene ,2005 ,24 : 2684 - 2694.
  • 3Piaskowski S,Rieske P,Szybka M,et al. GADD45A andEPB41 as tumor suppressor genes in meningioma pathogene-sis [ J ]. Cancer Genet Cytogenet, 2005 ,162 : 63 —67.
  • 4Fujita T, Igarashi J, Okawa ER, et al. CHD5, a tumorsuppressor gene deleted from lp36. 31 in neuroblastomas[J]. J Natl Cancer Inst, 2008,100:940 -949.
  • 5Thompson PM, Gotoh T, Kok, et al. CHD5 , a new mem-ber of the chromodomain gene family, is preferentially ex-pressed in the nervous system [ J ]. Oncogene, 2003,22 :1002-1011.
  • 6Mulero-Navarro S,Esteller M,Chromatin remodeling factorCHD5 is silenced by promoter CpG island hypermethylationin human cancer [ J]. Epigenetics,2008,3:210-215.
  • 7Zhao R, Yan Q, Lv J, et al. CHD5, a tumor suppressorthat is epigenetically silenced in lung cancer [ J ],LungCancer, 2012,76:324 -331.
  • 8Nguyen CT, Weisenberger DJ, Velicescu M. et al. HistoneH3-lysine 9 methylation is associated with aberrant gene si-lencing in cancer cells and is rapidly reversed by 5-Aza-2,-deoxycytidine[ J]. Cancer Res,2002,62:6456 - 6461.
  • 9韩琳琳,侯琳,宋金莲.甲硫氨酸合成酶多态性及CHD5基因甲基化与乳腺癌发病的关系[J].中国癌症杂志,2010,20(4):251-255. 被引量:7
  • 10刘丽乔,罗达亚,付晶晶,龚慧,万福生.5-Aza-CdR对人结肠癌Caco-2细胞系P16基因甲基化状态及其生物学表型的影响[J].基础医学与临床,2011,31(2):161-165. 被引量:6

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部